ETR:MRK MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding MERCK Kommanditgesellschaft auf Aktien Please log in to your account or sign up in order to add this asset to your watchlist. €165.70 +4.70 (+2.92%) (As of 07/1/2022 12:00 AM ET) Add Compare Share Today's Range€159.05▼€166.1050-Day Range€156.10▼€179.8552-Week Range€153.10▼€231.50Volume378,627 shsAverage VolumeN/AMarket Capitalization$21.42 billionP/E Ratio22.61Dividend Yield1.12%Price TargetN/A ProfileChartCompetitorsHeadlinesOptions Chain MERCK Kommanditgesellschaft auf Aktien MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.0.64 out of 5 stars 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for MERCK Kommanditgesellschaft auf Aktien. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for MRK. Previous Next 1.7 Dividend Strength Dividend YieldMERCK Kommanditgesellschaft auf Aktien pays a meaningful dividend of 1.12%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMERCK Kommanditgesellschaft auf Aktien does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of MERCK Kommanditgesellschaft auf Aktien is 25.24%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MRK. Previous Next 1.1 News and Social Media Coverage News SentimentMERCK Kommanditgesellschaft auf Aktien has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.Search InterestOnly 125 people have searched for MRK on MarketBeat in the last 30 days. This is a decrease of -9% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MERCK Kommanditgesellschaft auf Aktien insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of MERCK Kommanditgesellschaft auf Aktien is 22.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 75.04.Price to Earnings Ratio vs. SectorThe P/E ratio of MERCK Kommanditgesellschaft auf Aktien is 22.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 77.21.Price to Earnings Growth RatioMERCK Kommanditgesellschaft auf Aktien has a PEG Ratio of 1.79. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMERCK Kommanditgesellschaft auf Aktien has a P/B Ratio of 3.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MRK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MERCK Kommanditgesellschaft auf Aktien and its competitors with MarketBeat's FREE daily newsletter. Email Address About MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) StockMERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.Read More MRK Stock News HeadlinesMay 14, 2022 | finanznachrichten.deUBS stuft MERCK KGAA auf 'Neutral'May 14, 2022 | finanznachrichten.deBERENBERG stuft MERCK KGAA auf 'Hold'March 3, 2022 | finance.yahoo.comMerck KGaA predicts more earnings gains on lab supplies demandDecember 8, 2021 | finance.yahoo.comMerck invests nearly $700 million in M Ventures to seed young companiesNovember 13, 2021 | finanznachrichten.deKursverluste für die Aktie von MerckSeptember 21, 2021 | finance.yahoo.comNektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer StudySeptember 9, 2021 | ca.finance.yahoo.comMerck KGaA lifts growth forecast for life science tools businessAugust 5, 2021 | finance.yahoo.comMerck KGaA raises outlook after forecast-beating Q2 profitMarch 5, 2021 | finanznachrichten.deTreasuries Give Back Ground Amid Optimism About VaccinesMarch 4, 2021 | finance.yahoo.comMerck KGaA to Host Earnings CallNovember 13, 2020 | seekingalpha.comMERCK Kommanditgesellschaft auf Aktien's (MKGAF) Management on Q3 2020 Results - Earnings Call TranscriptOctober 16, 2020 | ca.finance.yahoo.comMERCK Kommanditgesellschaft auf Aktien (MRKC.SG)October 2, 2020 | seekingalpha.comMerck's head of research & development announces retirementOctober 2, 2020 | seekingalpha.comMerck Research Laboratories President bids adieuSeptember 25, 2020 | seekingalpha.comMerck (MRK) Presents at ESMO Virtual Congress - SlideshowSeptember 21, 2020 | seekingalpha.comMerck announces encouraging data on three pipeline candidates at ESMOSeptember 21, 2020 | seekingalpha.comMerck’s Keytruda delays recurrence and distant metastasis vs. placebo in skin cancerSeptember 11, 2020 | nasdaq.comMerck starts recruitment for COVID-19 vaccine trialSeptember 11, 2020 | seekingalpha.comMerck COVID-19 vaccine begins human testing in Belgium study - WSJSeptember 10, 2020 | nasdaq.comMerck's Pneumococcal Vaccine Meets Goals in Late-Stage StudiesSeptember 10, 2020 | finance.yahoo.comAnalyst Report: MERCK Kommanditgesellschaft auf AktienSeptember 9, 2020 | seekingalpha.comMerck's 15-valent pneumonia vaccine successful in late-stage studiesSeptember 4, 2020 | businesswire.comMerck to Present at the Citi 15th Annual BioPharma Virtual ConferenceAugust 27, 2020 | forbes.comMerck Vs JNJ, Merck's Got More MagicAugust 25, 2020 | msn.comMerck Analyst Raises Price Target Ahead Of Upcoming Antiviral Trial Results, PresentationSee More Headlines Industry, Sector and Symbol Stock ExchangeETR Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolETR:MRK CUSIPN/A CIKN/A Webwww.merckgroup.com Phone49 6151 72 0FaxN/AEmployees60,334Year FoundedN/ACompany Calendar Today7/04/2022Next Earnings (Estimated)8/04/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio22.61 Forward P/E Ratio16.03 P/E Growth1.79Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio46.24 Current Ratio1.09 Quick Ratio0.60 Sales & Book Value Annual Sales$20.25 billion Price / Sales1.06 Cash Flow€3.32 per share Price / Cash Flow49.95 Book Value€52.61 per share Price / Book3.15Miscellaneous Outstanding Shares129,242,000Free FloatN/AMarket Cap$21.42 billion OptionableOptionable BetaN/A MERCK Kommanditgesellschaft auf Aktien Frequently Asked Questions How has MERCK Kommanditgesellschaft auf Aktien's stock performed in 2022? MERCK Kommanditgesellschaft auf Aktien's stock was trading at €227.00 at the start of the year. Since then, MRK stock has decreased by 27.0% and is now trading at €165.70. View the best growth stocks for 2022 here. When is MERCK Kommanditgesellschaft auf Aktien's next earnings date? MERCK Kommanditgesellschaft auf Aktien is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for MERCK Kommanditgesellschaft auf Aktien. Is MERCK Kommanditgesellschaft auf Aktien a good dividend stock? MERCK Kommanditgesellschaft auf Aktien(ETR:MRK) pays an annual dividend of €1.85 per share and currently has a dividend yield of 1.12%. The dividend payout ratio of MERCK Kommanditgesellschaft auf Aktien is 25.24%. This payout ratio is at a healthy, sustainable level, below 75%. Who are MERCK Kommanditgesellschaft auf Aktien's key executives? MERCK Kommanditgesellschaft auf Aktien's management team includes the following people: Ms. Belen Garijo Lopez M.D., Chair of Exec. Board & CEO (Age 62, Pay $5.47M)Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 54, Pay $4.29M)Dr. Kai Beckmann, CEO of Electronics & Member of the Exec. Board (Age 57, Pay $4.31M)Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 60, Pay $2.12M)Dr. Matthias J. Heinzel, CEO of Life Science Sector & Member of Exec. Board (Age 55, Pay $1.61M)Mr. Gerhard Schmitz, Head of Global Accounting (Age 59)Mr. Dirk Toepfer, Chief Information OfficerMr. Constantin Fest, Head of Investor Relations (Age 45)Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 50)Ms. Barbara Weiland, Chief Compliance Officer (Age 48) Who are some of MERCK Kommanditgesellschaft auf Aktien's key competitors? Some companies that are related to MERCK Kommanditgesellschaft auf Aktien include Valeant Pharmaceuticals International (VRX), Aphria (APHA), Evotec (EVT), Bausch Health Companies (BHC), Hikma Pharmaceuticals (HIK), Canopy Growth (WEED), Hydropothecary (THCX), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Amryt Pharma (AMYT), HLS Therapeutics (HLS), OrganiGram (OGI), Benchmark (BMK), Supreme Cannabis (FIRE) and ESSA Pharma (EPI). View all of MRK's competitors. What other stocks do shareholders of MERCK Kommanditgesellschaft auf Aktien own? Based on aggregate information from My MarketBeat watchlists, some companies that other MERCK Kommanditgesellschaft auf Aktien investors own include AbbVie (ABBV), Chevron (CVX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Eli Lilly and (LLY), Medtronic (MDT), AT&T (T), Adobe (ADBE), Aldeyra Therapeutics (ALDX) and Amgen (AMGN). What is MERCK Kommanditgesellschaft auf Aktien's stock symbol? MERCK Kommanditgesellschaft auf Aktien trades on the ETR under the ticker symbol "MRK." What is MERCK Kommanditgesellschaft auf Aktien's stock price today? One share of MRK stock can currently be purchased for approximately €165.70. How much money does MERCK Kommanditgesellschaft auf Aktien make? MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) has a market capitalization of $21.42 billion and generates $20.25 billion in revenue each year. How many employees does MERCK Kommanditgesellschaft auf Aktien have? MERCK Kommanditgesellschaft auf Aktien employs 60,334 workers across the globe. How can I contact MERCK Kommanditgesellschaft auf Aktien? MERCK Kommanditgesellschaft auf Aktien's mailing address is 2000 Galloping Hill Rd, Kenilworth, New Jersey 07033-1310. The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com. The company can be reached via phone at 49 6151 72 0. This page (ETR:MRK) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
